— Know what they know.
Not Investment Advice

LIVN NASDAQ

LivaNova PLC
1W: +2.8% 1M: +13.0% 3M: +7.6% YTD: +21.4% 1Y: +64.1% 3Y: +57.5% 5Y: -12.4%
$73.83
+0.19 (+0.26%)
 
Weekly Expected Move ±9.7%
$56 $63 $70 $77 $84
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Buy · Power 72 · $4.1B mcap · 55M float · 1.62% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
54.0 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 17.2%  ·  5Y Avg: -3.1%
Cost Advantage ★
71
Intangibles
48
Switching Cost
47
Network Effect
67
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. LIVN shows a Weak competitive edge (54.0/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 17.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$76
Low
$83
Avg Target
$90
High
Based on 2 analysts since May 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 10Hold: 3Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$81.75
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-07 Mizuho Securities $72 $90 +18 +35.8% $66.26
2026-05-07 Barclays $67 $76 +9 +14.7% $66.26
2026-02-25 Stifel Nicolaus $72 $80 +8 +13.8% $70.29
2026-02-25 Needham Mike Matson $88 $81 -7 +15.2% $70.29
2026-02-19 Piper Sandler Adam Maeder Initiated $85 +26.2% $67.33
2026-01-09 Barclays $56 $67 +11 +3.2% $64.95
2026-01-09 Goldman Sachs David Roman $55 $66 +11 +1.6% $64.95
2025-12-18 KeyBanc Brett Fishbin Initiated $81 +30.5% $62.08
2025-12-17 Mizuho Securities Anthony Petrone $70 $72 +2 +14.1% $63.08
2025-12-16 Robert W. Baird $66 $75 +9 +19.0% $63.05
2025-10-01 Goldman Sachs $65 $55 -10 +5.0% $52.38
2025-03-07 Barclays $62 $56 -6 +43.0% $39.17
2024-10-31 Mizuho Securities Anthony Petrone Initiated $70 +37.1% $51.05
2024-10-04 Goldman Sachs David Roman $63 $65 +2 +20.6% $53.90
2024-09-17 Robert W. Baird David Rescott Initiated $66 +35.3% $48.79
2024-07-25 Stifel Nicolaus Rick Wise $70 $72 +2 +34.7% $53.45
2024-06-06 Stifel Nicolaus Rick Wise $65 $70 +5 +31.7% $53.16
2024-03-20 Stifel Nicolaus Rick Wise Initiated $65 +14.8% $56.63
2022-12-21 Barclays Initiated $62 +10.6% $56.05
2022-11-23 Goldman Sachs $73 $63 -10 +16.8% $53.95
2022-08-16 Goldman Sachs Initiated $73 +14.3% $63.86
2022-08-04 Needham Initiated $88 +39.9% $62.89

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
4
ROE
4
ROA
4
D/E
2
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. LIVN receives an overall rating of B. Strongest factors: DCF (4/5), ROE (4/5), ROA (4/5). Areas of concern: D/E (2/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-18 B+ B
2026-05-06 C+ B+
2026-05-04 C C+
2026-03-02 C+ C
2026-02-26 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

60 Grade A
Profitability
45
Balance Sheet
73
Earnings Quality
74
Growth
66
Value
38
Momentum
92
Safety
50
Cash Flow
61
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. LIVN scores highest in Momentum (92/100) and lowest in Value (38/100). An overall grade of A places LIVN among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.44
Grey Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.71
Unlikely Manipulator
Ohlson O-Score
-7.93
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 61.4/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 2.29x
Accruals: -5.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LIVN scores 2.44, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LIVN scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. LIVN's score of -2.71 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LIVN's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LIVN receives an estimated rating of BBB+ (score: 61.4/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). LIVN's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
37.69x
PEG
0.31x
P/S
2.83x
P/B
3.33x
P/FCF
22.06x
P/OCF
14.47x
EV/EBITDA
14.56x
EV/Revenue
2.37x
EV/EBIT
17.85x
EV/FCF
21.05x
Earnings Yield
3.02%
FCF Yield
4.53%
Shareholder Yield
0.12%
Graham Number
$30.43
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 37.7x earnings, LIVN commands a growth premium. Graham's intrinsic value formula yields $30.43 per share, 143% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.882
NI / EBT
×
Interest Burden
0.640
EBT / EBIT
×
EBIT Margin
0.133
EBIT / Rev
×
Asset Turnover
0.561
Rev / Assets
×
Equity Multiplier
2.029
Assets / Equity
=
ROE
8.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LIVN's ROE of 8.5% is driven by Asset Turnover (0.561), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$16.29
Price/Value
3.90x
Margin of Safety
-290.15%
Premium
290.15%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with LIVN's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. LIVN trades at a 290% premium to its adjusted intrinsic value of $16.29, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 37.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$73.83
Median 1Y
$64.78
5th Pctile
$31.54
95th Pctile
$132.30
Ann. Volatility
44.0%
Analyst Target
$81.75
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Damien McDonald,
Former CEO
$286,826 $4,746,297 $8,210,340
Marco Dolci, President,
sident, Cardiopulmonary BU
$571,833 $2,094,554 $4,802,288
William Kozy, Interim
Interim CEO
$697,500 $1,249,961 $3,060,725
Alex Shvartsburg,
CFO
$536,885 $1,168,289 $2,771,180
Michael Hutchinson, President,
e President, Chief Legal Officer and Company Secretary
$505,077 $730,181 $2,072,351
Trui Hebbelinck, CHRO
$396,347 $657,120 $1,777,160

CEO Pay Ratio

49:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $8,210,340
Avg Employee Cost (SGA/emp): $166,303
Employees: 3,300

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3,300
+13.8% YoY
Revenue / Employee
$420,636
Rev: $1,388,100,000
Profit / Employee
$-73,485
NI: $-242,500,000
SGA / Employee
$166,303
Avg labor cost proxy
R&D / Employee
$56,303
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -30.9% -33.2% -11.6% -8.8% -2.7% -8.0% -6.9% -6.5% -7.8% 0.2% 1.4% -2.6% -1.3% 1.9% 4.9% -17.1% -16.3% -16.7% -19.2% 8.5% 8.50%
ROA -16.0% -17.2% -6.1% -4.6% -1.4% -4.2% -3.8% -3.6% -4.3% 0.1% 0.7% -1.3% -0.7% 1.0% 2.6% -9.0% -8.6% -8.8% -9.5% 4.2% 4.19%
ROIC -15.0% -14.0% -0.3% 0.6% 4.5% -4.0% -3.9% -4.4% -5.2% 0.3% -3.3% -2.4% -1.3% 0.2% 5.9% 8.1% 8.8% 9.8% 15.2% 17.2% 17.24%
ROCE -4.5% -5.8% -4.2% -3.5% 1.1% -3.1% -1.3% -0.9% -1.5% 3.8% -1.1% -3.1% -2.2% 0.0% 7.2% -6.2% -5.8% -6.5% -9.0% 10.6% 10.57%
Gross Margin 65.1% 66.6% 73.1% 70.1% 72.5% 67.7% 66.8% 66.1% 69.8% 70.5% 61.3% 70.3% 67.4% 70.8% 68.2% 69.7% 67.8% 68.4% 66.4% 67.6% 67.59%
Operating Margin -13.7% 6.5% 7.6% 4.0% 12.5% -52.2% 5.1% -0.9% 5.9% 1.6% -28.4% 5.5% 12.6% 11.2% 11.5% 15.3% 15.4% 15.1% 11.8% 14.4% 14.41%
Net Margin -21.4% -17.2% -3.2% 1.2% 6.5% -42.5% 0.6% 2.8% 0.4% -2.6% 5.3% -14.2% 5.1% 10.4% 17.4% -1.0% 7.7% 7.5% 8.6% 6.2% 6.16%
EBITDA Margin -7.4% -5.6% 6.4% 11.7% 18.7% -31.6% 12.7% 14.5% 11.9% 9.8% -20.2% -1.8% 15.5% 23.1% 26.4% -90.2% 17.2% 15.9% 13.2% 18.7% 18.71%
FCF Margin 5.7% 7.8% 7.4% 8.4% 5.0% 5.9% 4.2% 3.4% 2.6% 0.8% 3.5% 2.6% 7.0% 8.8% 10.8% 11.4% 12.4% 14.2% 12.5% 11.2% 11.24%
OCF Margin 8.8% 10.2% 9.9% 10.6% 7.2% 8.3% 6.8% 6.2% 5.3% 3.5% 6.5% 5.4% 10.4% 12.7% 14.6% 15.4% 16.5% 18.6% 18.3% 17.1% 17.13%
ROE 3Y Avg snapshot only -3.46%
ROE 5Y Avg snapshot only -5.06%
ROA 3Y Avg snapshot only -2.02%
ROIC 3Y Avg snapshot only 0.26%
ROIC Economic snapshot only 10.88%
Cash ROA snapshot only 9.42%
Cash ROIC snapshot only 23.67%
CROIC snapshot only 15.52%
NOPAT Margin snapshot only 12.48%
Pretax Margin snapshot only 8.48%
R&D / Revenue snapshot only 13.74%
SGA / Revenue snapshot only 39.29%
SBC / Revenue snapshot only 0.64%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -10.67 -9.86 -33.46 -42.02 -103.76 -28.17 -34.65 -28.69 -28.58 995.65 160.12 -95.09 -180.40 121.10 40.06 -9.62 -11.66 -13.30 -13.83 33.16 37.694
P/S Ratio 4.03 3.95 4.50 4.31 3.32 2.67 2.92 2.25 2.56 2.55 2.44 2.55 2.47 2.31 2.02 1.68 1.88 2.14 2.42 2.48 2.829
P/B Ratio 3.71 3.68 3.60 3.42 2.61 2.10 2.47 1.95 2.30 2.36 2.20 2.36 2.34 2.24 1.92 1.62 1.87 2.19 2.79 2.96 3.334
P/FCF 70.12 50.30 60.76 51.53 66.51 45.50 68.84 65.49 96.98 337.57 70.36 99.24 35.11 26.39 18.64 14.69 15.19 15.10 19.35 22.06 22.058
P/OCF 45.54 38.65 45.61 40.86 46.29 32.09 42.73 36.22 48.64 72.12 37.53 47.14 23.86 18.12 13.84 10.85 11.37 11.54 13.18 14.47 14.467
EV/EBITDA -162.89 -75.73 -7884.74 386.56 43.83 210.34 108.54 66.37 110.91 23.66 82.72 -700.94 352.82 59.06 13.73 -30.59 -40.60 -37.73 -26.47 14.56 14.558
EV/Revenue 4.47 4.39 4.58 4.39 3.40 2.75 3.28 2.60 2.90 2.88 2.76 2.86 2.78 2.61 2.22 1.87 2.07 2.33 2.30 2.37 2.365
EV/EBIT -48.21 -37.53 -74.98 -85.30 209.36 -59.85 -124.73 -158.82 -103.42 42.36 -142.29 -53.14 -71.85 7078.16 18.37 -18.26 -22.18 -22.79 -19.63 17.85 17.847
EV/FCF 77.90 55.92 61.79 52.44 68.06 46.82 77.28 75.70 109.77 380.87 79.73 111.52 39.50 29.83 20.46 16.39 16.72 16.40 18.41 21.05 21.050
Earnings Yield -9.4% -10.1% -3.0% -2.4% -1.0% -3.5% -2.9% -3.5% -3.5% 0.1% 0.6% -1.1% -0.6% 0.8% 2.5% -10.4% -8.6% -7.5% -7.2% 3.0% 3.02%
FCF Yield 1.4% 2.0% 1.6% 1.9% 1.5% 2.2% 1.5% 1.5% 1.0% 0.3% 1.4% 1.0% 2.8% 3.8% 5.4% 6.8% 6.6% 6.6% 5.2% 4.5% 4.53%
PEG Ratio snapshot only 0.315
Price/Tangible Book snapshot only 20.051
EV/OCF snapshot only 13.806
EV/Gross Profit snapshot only 3.501
Acquirers Multiple snapshot only 16.704
Shareholder Yield snapshot only 0.12%
Graham Number snapshot only $30.43
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.29 2.29 0.97 0.97 0.97 0.97 2.98 2.98 2.98 2.98 2.95 2.95 2.95 2.95 2.87 2.87 2.87 2.87 1.36 1.36 1.363
Quick Ratio 1.92 1.92 0.82 0.82 0.82 0.82 2.54 2.54 2.54 2.54 2.51 2.51 2.51 2.51 2.50 2.50 2.50 2.50 1.16 1.16 1.159
Debt/Equity 0.64 0.64 0.22 0.22 0.22 0.22 0.48 0.48 0.48 0.48 0.50 0.50 0.50 0.50 0.51 0.51 0.51 0.51 0.39 0.39 0.394
Net Debt/Equity 0.41 0.41 0.06 0.06 0.06 0.06 0.30 0.30 0.30 0.30 0.29 0.29 0.29 0.29 0.19 0.19 0.19 0.19 -0.14 -0.14 -0.135
Debt/Assets 0.30 0.30 0.13 0.13 0.13 0.13 0.25 0.25 0.25 0.25 0.26 0.26 0.26 0.26 0.27 0.27 0.27 0.27 0.18 0.18 0.182
Debt/EBITDA -25.27 -11.83 -477.04 24.56 3.63 21.56 18.78 14.19 20.48 4.26 16.64 -132.23 67.11 11.67 3.34 -8.68 -10.14 -8.13 -3.93 2.03 2.032
Net Debt/EBITDA -16.26 -7.61 -130.97 6.74 1.00 5.92 11.85 8.95 12.92 2.69 9.72 -77.20 39.18 6.81 1.22 -3.18 -3.71 -2.98 1.35 -0.70 -0.697
Interest Coverage -1.50 -2.02 -1.26 -1.26 0.41 -1.13 -0.56 -0.32 -0.56 1.34 -0.38 -1.04 -0.76 0.01 2.40 -2.09 -2.06 -2.54 -2.79 3.71 3.709
Equity Multiplier 2.16 2.16 1.70 1.70 1.70 1.70 1.90 1.90 1.90 1.90 1.90 1.90 1.90 1.90 1.90 1.90 1.90 1.90 2.17 2.17 2.172
Cash Ratio snapshot only 0.787
Debt Service Coverage snapshot only 4.547
Cash to Debt snapshot only 1.343
FCF to Debt snapshot only 0.340
Defensive Interval snapshot only 406.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.42 0.43 0.45 0.45 0.44 0.44 0.45 0.46 0.48 0.50 0.49 0.50 0.51 0.53 0.51 0.52 0.53 0.55 0.54 0.56 0.561
Inventory Turnover 2.81 2.72 3.02 2.90 2.70 2.68 2.67 2.82 2.98 3.01 2.76 2.74 2.85 2.91 2.62 2.67 2.74 2.88 2.84 2.98 2.978
Receivables Turnover 4.62 4.68 5.60 5.56 5.50 5.50 5.55 5.67 5.89 6.07 5.79 5.95 6.08 6.24 6.14 6.25 6.41 6.61 6.78 7.01 7.007
Payables Turnover 4.91 4.75 4.71 4.53 4.22 4.18 4.42 4.67 4.93 4.97 4.93 4.90 5.10 5.21 5.13 5.25 5.38 5.65 5.31 5.57 5.570
DSO 79 78 65 66 66 66 66 64 62 60 63 61 60 59 59 58 57 55 54 52 52.1 days
DIO 130 134 121 126 135 136 136 129 122 121 132 133 128 125 139 136 133 127 128 123 122.6 days
DPO 74 77 78 81 87 87 83 78 74 73 74 74 72 70 71 70 68 65 69 66 65.5 days
Cash Conversion Cycle 135 136 109 111 115 115 120 115 110 108 121 120 116 114 128 125 122 117 114 109 109.1 days
Fixed Asset Turnover snapshot only 4.809
Operating Cycle snapshot only 174.7 days
Cash Velocity snapshot only 2.255
Capital Intensity snapshot only 1.818
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 4.2% 8.7% 10.8% 9.4% -0.4% -1.7% -1.3% 1.7% 6.6% 10.0% 12.9% 13.4% 11.5% 11.0% 8.7% 7.6% 8.2% 8.6% 10.7% 12.4% 12.39%
Net Income -1.4% -98.8% 60.1% 74.7% 91.6% 76.7% 38.1% 22.4% -2.0% 1.0% 1.2% 61.2% 82.9% 7.3% 2.6% -6.0% -11.7% -10.2% -4.8% 1.5% 1.48%
EPS -1.4% -87.5% 63.6% 77.2% 92.4% 77.6% 38.6% 22.0% -2.0% 1.0% 1.2% 61.3% 83.1% 7.2% 2.6% -5.9% -11.7% -10.1% -4.8% 1.5% 1.47%
FCF 1.3% 1.5% 1.7% 6.5% -13.4% -26.4% -43.4% -58.3% -43.6% -85.8% -8.0% -15.1% 2.0% 11.8% 2.4% 3.8% 90.2% 76.2% 27.5% 10.7% 10.69%
EBITDA 50.9% 31.3% 88.0% 3.3% 3.8% 1.2% 52.4% 2.5% -64.1% 9.2% 24.5% -1.1% -66.3% -59.7% 4.3% -15.1% -8.0% -2.5% -1.6% 4.0% 3.99%
Op. Income -1.7% -98.9% 98.0% 1.0% 1.3% 74.7% -14.6% -9.6% -2.3% 1.5% 10.8% 43.7% 73.7% -87.9% 2.9% 4.2% 7.5% 47.0% 54.5% 25.7% 25.75%
OCF Growth snapshot only 24.65%
Asset Growth snapshot only 3.98%
Equity Growth snapshot only -9.11%
Debt Growth snapshot only -30.07%
Shares Change snapshot only 2.72%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -3.2% -1.7% -2.2% -2.5% -2.5% -2.4% -2.0% -1.0% 3.4% 5.5% 7.3% 8.0% 5.8% 6.3% 6.6% 7.5% 8.8% 9.9% 10.8% 11.1% 11.11%
Revenue 5Y 10.9% 2.8% -3.1% -3.2% -3.4% -3.7% -3.1% -2.1% -0.7% 0.5% 0.8% 1.4% 2.0% 2.6% 2.9% 3.5% 5.9% 7.2% 8.2% 8.8% 8.82%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y 78.6% 78.56%
EBITDA 5Y -41.2% -13.3% -39.0% -30.3% -25.4% -29.5% 2.9%
Gross Profit 3Y -4.7% -2.3% -1.5% -1.3% -0.9% -1.0% -1.7% -1.8% 3.0% 6.4% 9.9% 11.9% 8.9% 8.5% 7.3% 7.6% 7.9% 8.6% 10.1% 10.8% 10.76%
Gross Profit 5Y 12.2% 3.9% -0.1% -0.6% -0.8% -1.0% -1.6% -0.9% 0.2% 1.7% 1.0% 1.8% 2.0% 2.4% 3.1% 3.2% 6.2% 7.8% 10.2% 11.0% 11.04%
Op. Income 3Y 1.5% 30.8%
Op. Income 5Y -6.4%
FCF 3Y -8.2% -0.4% -2.4% 10.3% 41.4% 38.5% 13.2% 10.2% 21.0% 19.1% 47.2% 47.4% 58.7% 65.0% 64.98%
FCF 5Y 31.4% 8.1% 2.3% -6.9% -5.9% -5.4% -4.9% -17.7% -36.5% -13.5% -13.8% 36.5% 69.7% 69.67%
OCF 3Y -5.8% -3.4% -5.4% 2.1% 10.2% 11.6% 11.5% 14.4% 21.5% 22.0% 43.7% 43.6% 53.8% 55.9% 55.87%
OCF 5Y 48.3% 16.4% 2.5% -0.9% -7.7% -5.8% -5.2% -3.8% -12.0% -19.5% -9.1% -8.9% 18.1% 39.7% 39.73%
Assets 3Y -1.4% -1.4% -4.8% -4.8% -4.8% -4.8% -1.6% -1.6% -1.6% -1.6% 0.4% 0.4% 0.4% 0.4% 4.4% 4.4% 4.4% 4.4% 4.3% 4.3% 4.33%
Assets 5Y -1.3% -1.3% -1.2% -1.2% -1.2% -1.2% -1.7% -1.7% -1.7% -1.7% -1.0% -1.0% -1.0% -1.0% 0.8% 0.8% 0.8% 0.8% 1.7% 1.7% 1.66%
Equity 3Y -15.1% -15.1% -4.9% -4.9% -4.9% -4.9% -4.4% -4.4% -4.4% -4.4% 4.8% 4.8% 4.8% 4.8% 0.7% 0.7% 0.7% 0.7% -0.2% -0.2% -0.21%
Book Value 3Y -14.9% -16.8% -7.8% -8.5% -8.4% -7.7% -7.7% -7.6% -7.7% -7.7% 1.0% 1.3% 1.1% 2.9% -0.2% 0.5% 0.3% -0.4% -0.6% -1.4% -1.42%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.42 0.14 0.72 0.76 0.74 0.65 0.53 0.40 0.08 0.02 0.04 0.09 0.21 0.32 0.43 0.55 0.88 0.93 0.95 0.96 0.957
Earnings Stability 0.76 0.83 0.39 0.29 0.17 0.33 0.03 0.01 0.01 0.06 0.41 0.25 0.44 0.50 0.67 0.05 0.10 0.20 0.18 0.48 0.482
Margin Stability 0.93 0.95 0.93 0.93 0.94 0.95 0.95 0.94 0.95 0.95 0.96 0.95 0.95 0.96 0.99 0.99 0.98 0.98 0.96 0.95 0.952
Rev. Growth Consistency 0.50 0.50 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.500
FCF Positive Streak 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.85 0.91 0.50 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.200
Earnings Smoothness 0.00 0.00
ROE Trend -0.20 -0.22 0.11 0.14 0.21 0.19 0.14 0.16 0.11 0.23 0.10 0.05 0.04 0.05 0.08 -0.12 -0.11 -0.18 -0.23 0.19 0.186
Gross Margin Trend -0.06 -0.04 0.02 0.03 0.06 0.06 0.04 0.03 0.01 0.01 -0.02 -0.01 -0.02 -0.02 0.01 0.01 0.02 0.01 0.00 -0.01 -0.009
FCF Margin Trend 0.17 0.21 0.19 0.18 0.14 0.10 0.07 -0.01 -0.03 -0.06 -0.02 -0.03 0.03 0.05 0.07 0.08 0.08 0.09 0.05 0.04 0.042
Sustainable Growth Rate 0.2% 1.4% 1.9% 4.9% 8.5% 8.50%
Internal Growth Rate 0.1% 0.7% 1.0% 2.6% 4.4% 4.37%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -0.23 -0.26 -0.73 -1.03 -2.24 -0.88 -0.81 -0.79 -0.59 13.81 4.27 -2.02 -7.56 6.68 2.89 -0.89 -1.02 -1.15 -1.05 2.29 2.292
FCF/OCF 0.65 0.77 0.75 0.79 0.70 0.71 0.62 0.55 0.50 0.21 0.53 0.48 0.68 0.69 0.74 0.74 0.75 0.76 0.68 0.66 0.656
FCF/Net Income snapshot only 1.503
OCF/EBITDA snapshot only 1.054
CapEx/Revenue 3.1% 2.4% 2.5% 2.2% 2.2% 2.5% 2.6% 2.8% 2.6% 2.8% 3.0% 2.8% 3.3% 4.0% 3.8% 4.0% 4.2% 4.4% 5.8% 5.9% 5.90%
CapEx/Depreciation snapshot only 1.969
Accruals Ratio -0.20 -0.22 -0.10 -0.09 -0.05 -0.08 -0.07 -0.07 -0.07 -0.02 -0.02 -0.04 -0.06 -0.06 -0.05 -0.17 -0.17 -0.19 -0.19 -0.05 -0.054
Sloan Accruals snapshot only -0.190
Cash Flow Adequacy snapshot only 2.906
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 2.5% 39.9% 34.1% 13.3% 4.1% 4.13%
Div. Increase Streak
Chowder Number
Buyback Yield 0.3% 0.3% 0.3% 0.2% 0.3% 0.3% 0.3% 0.4% 0.2% 0.2% 0.2% 0.2% 0.3% 0.3% 0.3% 0.4% 0.2% 0.1% 0.1% 0.1% 0.12%
Net Buyback Yield 0.2% 0.3% 0.3% 0.2% 0.3% 0.3% 0.2% 0.3% 0.2% 0.2% 0.2% 0.2% 0.3% 0.3% 0.3% 0.4% 0.2% 0.1% 0.1% 0.1% 0.12%
Total Shareholder Return 0.2% 0.3% 0.3% 0.2% 0.3% 0.3% 0.2% 0.3% 0.2% 0.2% 0.2% 0.2% 0.3% 0.3% 0.3% 0.4% 0.2% 0.1% 0.1% 0.1% 0.12%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.06 1.07 1.08 1.11 1.38 1.10 1.15 1.15 1.15 0.15 -0.22 0.25 0.15 -0.38 0.72 1.15 1.16 1.13 1.10 0.88 0.882
Interest Burden (EBT/EBIT) 3.84 3.20 2.04 1.80 -1.43 1.88 2.80 4.15 2.79 0.25 3.63 1.96 2.33 -136.37 0.58 1.48 1.48 1.39 1.36 0.64 0.640
EBIT Margin -0.09 -0.12 -0.06 -0.05 0.02 -0.05 -0.03 -0.02 -0.03 0.07 -0.02 -0.05 -0.04 0.00 0.12 -0.10 -0.09 -0.10 -0.12 0.13 0.133
Asset Turnover 0.42 0.43 0.45 0.45 0.44 0.44 0.45 0.46 0.48 0.50 0.49 0.50 0.51 0.53 0.51 0.52 0.53 0.55 0.54 0.56 0.561
Equity Multiplier 1.93 1.93 1.91 1.91 1.91 1.91 1.80 1.80 1.80 1.80 1.90 1.90 1.90 1.90 1.90 1.90 1.90 1.90 2.03 2.03 2.029
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-7.88 $-8.03 $-2.61 $-1.95 $-0.60 $-1.80 $-1.60 $-1.52 $-1.80 $0.05 $0.32 $-0.59 $-0.30 $0.43 $1.16 $-4.08 $-3.86 $-3.94 $-4.45 $1.92 $1.92
Book Value/Share $22.67 $21.50 $24.29 $23.90 $23.93 $24.18 $22.45 $22.40 $22.36 $22.36 $23.53 $23.66 $23.40 $23.41 $24.14 $24.26 $24.13 $23.92 $22.02 $21.47 $22.15
Tangible Book/Share $-5.12 $-4.86 $-0.09 $-0.08 $-0.08 $-0.09 $1.31 $1.30 $1.30 $1.30 $4.30 $4.32 $4.28 $4.28 $6.09 $6.12 $6.09 $6.03 $3.25 $3.17 $3.17
Revenue/Share $20.88 $20.06 $19.43 $18.97 $18.81 $19.00 $18.99 $19.39 $20.09 $20.71 $21.24 $21.95 $22.16 $22.75 $22.91 $23.44 $23.93 $24.44 $25.47 $25.64 $26.21
FCF/Share $1.20 $1.57 $1.44 $1.59 $0.94 $1.12 $0.81 $0.67 $0.53 $0.16 $0.74 $0.56 $1.56 $1.99 $2.49 $2.67 $2.96 $3.47 $3.18 $2.88 $2.94
OCF/Share $1.85 $2.05 $1.92 $2.00 $1.35 $1.58 $1.30 $1.20 $1.06 $0.73 $1.38 $1.19 $2.30 $2.90 $3.35 $3.62 $3.96 $4.54 $4.67 $4.39 $4.49
Cash/Share $5.17 $4.90 $3.90 $3.84 $3.84 $3.89 $3.98 $3.97 $3.97 $3.97 $4.91 $4.94 $4.88 $4.88 $7.84 $7.88 $7.84 $7.77 $11.66 $11.37 $9.87
EBITDA/Share $-0.57 $-1.16 $-0.01 $0.22 $1.46 $0.25 $0.57 $0.76 $0.52 $2.52 $0.71 $-0.09 $0.17 $1.01 $3.70 $-1.43 $-1.22 $-1.51 $-2.21 $4.17 $4.17
Debt/Share $14.49 $13.75 $5.38 $5.29 $5.30 $5.36 $10.79 $10.77 $10.75 $10.75 $11.79 $11.86 $11.73 $11.73 $12.37 $12.44 $12.37 $12.26 $8.68 $8.47 $8.47
Net Debt/Share $9.33 $8.85 $1.48 $1.45 $1.45 $1.47 $6.81 $6.80 $6.78 $6.78 $6.89 $6.92 $6.85 $6.85 $4.53 $4.56 $4.53 $4.49 $-2.98 $-2.90 $-2.90
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.442
Altman Z-Prime snapshot only 3.882
Piotroski F-Score 5 5 5 5 5 5 5 6 6 8 6 6 5 7 7 4 5 4 5 6 6
Beneish M-Score -3.49 -3.84 -2.98 -2.81 -2.59 -2.73 -2.81 -2.80 -2.81 -2.64 -2.53 -2.68 -2.72 -2.71 -2.74 -3.24 -3.27 -3.31 -3.36 -2.71 -2.705
Ohlson O-Score snapshot only -7.934
ROIC (Greenblatt) snapshot only 32.11%
Net-Net WC snapshot only $-5.45
EVA snapshot only $75161741.33
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB+
Credit Score 43.61 44.48 45.45 42.96 39.64 26.68 35.58 34.99 34.20 47.50 35.53 43.12 36.83 38.79 59.04 47.52 47.75 46.64 51.51 61.40 61.400
Credit Grade snapshot only 8
Credit Trend snapshot only 13.885
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 56
Sector Credit Rank snapshot only 53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms